Cargando…

E-diary use in clinical headache practice: A prospective observational study

AIM: To determine whether our E-diary can be used to diagnose migraine and provide more reliable migraine-related frequency numbers compared to patients’ self-reported estimates. METHODS: We introduced a self-developed E-diary including automated algorithms differentiating headache and migraine days...

Descripción completa

Detalles Bibliográficos
Autores principales:	van Casteren, Daphne S, Verhagen, Iris E, de Boer, Irene, de Vries Lentsch, Simone, Fronczek, Rolf, van Zwet, Erik W, MaassenVanDenBrink, Antoinette, Terwindt, Gisela M
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	SAGE Publications 2021
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8504420/ https://www.ncbi.nlm.nih.gov/pubmed/33938248 http://dx.doi.org/10.1177/03331024211010306

Ejemplares similares

Comparing Perimenstrual and Nonperimenstrual Migraine Attacks Using an e-Diary
por: van Casteren, Daphne S., et al.
Publicado: (2021)

Sex differences in prevalence of migraine trigger factors: A cross-sectional study
por: van Casteren, Daphne S, et al.
Publicado: (2020)

Clinical symptoms of androgen deficiency in men with migraine or cluster headache: a cross-sectional cohort study
por: Verhagen, Iris E., et al.
Publicado: (2021)

Treatment with the monoclonal calcitonin gene‐related peptide receptor antibody erenumab: A real‐life study
por: de Vries Lentsch, Simone, et al.
Publicado: (2021)

Correction to: Clinical symptoms of androgen deficiency in men with migraine or cluster headache: a cross-sectional cohort study
por: Verhagen, Iris E., et al.
Publicado: (2021)

Validation of diagnostic ICHD-3 criteria for menstrual migraine
por: Verhagen, Iris E, et al.
Publicado: (2022)

Jealousy in women with migraine: a cross-sectional case-control study
por: van Casteren, Daphne S., et al.
Publicado: (2020)

Effect of lockdown during COVID-19 on migraine: A longitudinal cohort study
por: Verhagen, Iris E, et al.
Publicado: (2021)

The potential danger of blocking CGRP for treating migraine in CADASIL patients
por: de Boer, Irene, et al.
Publicado: (2020)

Serum CGRP in migraine patients using erenumab as preventive treatment
por: de Vries Lentsch, Simone, et al.
Publicado: (2022)

Pain perception in women with menstrually-related migraine
por: Linstra, Katie M, et al.
Publicado: (2020)

Headache medication and the COVID-19 pandemic
por: MaassenVanDenBrink, Antoinette, et al.
Publicado: (2020)

Blood Pressure in Patients With Migraine Treated With Monoclonal Anti-CGRP (Receptor) Antibodies: A Prospective Follow-up Study
por: de Vries Lentsch, Simone, et al.
Publicado: (2022)

Calcitonin gene-related peptide (receptor) antibodies: an exciting avenue for migraine treatment
por: MaassenVanDenBrink, Antoinette, et al.
Publicado: (2018)

The need for new acutely acting antimigraine drugs: moving safely outside acute medication overuse
por: van Hoogstraten, Willem Sebastiaan, et al.
Publicado: (2019)

PACAP38 and PAC(1) receptor blockade: a new target for headache?
por: Rubio-Beltrán, Eloisa, et al.
Publicado: (2018)

Could erectile dysfunction be a side effect of CGRP inhibition? A case report
por: Al-Hassany, Linda, et al.
Publicado: (2021)

Impact of age and sex on the efficacy of fremanezumab in patients with difficult-to-treat migraine: results of the randomized, placebo-controlled, phase 3b FOCUS study
por: MaassenVanDenBrink, Antoinette, et al.
Publicado: (2021)

Blocking the CGRP Receptor: Differences across Human Vascular Beds
por: de Vries, Tessa, et al.
Publicado: (2023)

Comment on “A second trigeminal CGRP receptor: function and expression of the AMY1 receptor”
por: Haanes, Kristian Agmund, et al.
Publicado: (2016)

Protective effects of PACAP in ischemia
por: Reglodi, Dora, et al.
Publicado: (2018)

Endothelin-converting-enzyme 1 inhibition and CGRP receptor recycling in human coronary and middle meningeal arteries
por: Labruijere, S, et al.
Publicado: (2013)

Chronobiology and Sleep in Cluster Headache
por: de Coo, Ilse F., et al.
Publicado: (2019)

Sumatriptan and dihydroergotamine in proximal and distal human isolated coronary arteries
por: Labruijere, S, et al.
Publicado: (2013)

Comparison of the vasodilator responses of isolated human and rat middle meningeal arteries to migraine related compounds
por: Grände, Gustaf, et al.
Publicado: (2014)

Gender aspects of CGRP in migraine
por: Labastida-Ramírez, Alejandro, et al.
Publicado: (2017)

Metabolic Aspects of Migraine: Association With Obesity and Diabetes Mellitus
por: Rivera-Mancilla, Eduardo, et al.
Publicado: (2021)

European Headache Federation guideline on the use of monoclonal antibodies targeting the calcitonin gene related peptide pathway for migraine prevention – 2022 update
por: Sacco, Simona, et al.
Publicado: (2022)

Behavioural intervention in medication overuse headache: A concealed double‐blind randomized controlled trial
por: Pijpers, Judith A., et al.
Publicado: (2022)

Revisiting dose-finding of monoclonal antibodies in migraine
por: Al-Hassany, Linda, et al.
Publicado: (2023)

Serotonergic Modulation of Neurovascular Transmission: A Focus on Prejunctional 5-HT Receptors/Mechanisms
por: González-Hernández, Abimael, et al.
Publicado: (2023)

European Headache Federation (EHF) critical re-appraisal and meta-analysis of oral drugs in migraine prevention—part 2: flunarizine
por: Deligianni, Christina I., et al.
Publicado: (2023)

Debate: Are cluster headache and migraine distinct headache disorders?
por: Al-Karagholi, Mohammad Al-Mahdi, et al.
Publicado: (2022)

Giving Researchers a Headache – Sex and Gender Differences in Migraine
por: Al-Hassany, Linda, et al.
Publicado: (2020)

Persistent post-traumatic headache: a migrainous loop or not? The preclinical evidence
por: Benemei, Silvia, et al.
Publicado: (2020)

Cutaneous allodynia as predictor for treatment response in chronic migraine: a cohort study
por: Pijpers, Judith A., et al.
Publicado: (2023)

17β-estradiol and methylation of migraine-related genes
por: Labruijere, S, et al.
Publicado: (2013)

European Headache Federation (EHF) critical re-appraisal and meta-analysis of oral drugs in migraine prevention—part 1: amitriptyline
por: Lampl, Christian, et al.
Publicado: (2023)

EHMTI-0096. Efficacy of sumatriptan: assessment of a possible biomarker
por: Ibrahimi, K, et al.
Publicado: (2014)

Extracranial Trigger Site Surgery for Migraine: A Systematic Review With Meta-Analysis on Elimination of Headache Symptoms
por: Vincent, Arnaud J. P. E., et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_ssv9ra4h1ctvenuo93mqvbfa1c